Deoxycytidine is a deoxyribonucleoside, a component of deoxyribonucleic acid. It is similar to the ribonucleoside cytidine, but with one hydroxyl group removed from the C2' position.
Deoxycytidine can be phosphorylated at C5' of the deoxyribose by deoxycytidine kinase, converting it to deoxycytidine monophosphate (dCMP), a DNA precursor. dCMP can be converted to dUMP and dTMP.
It can also be used as a precursor for 5-aza-2′-deoxycytidine, a treatment for MDS patients. This compound slows the cell cycle by interfering with the methylation of the P15/INK4B gene, increasing the expression of P15/INK4B protein which subdues the transformation of MDS to leukemia.
Deoxycytidine can also serve as a biomarker for tumor diagnosis. Deoxycytidine can be used as a biomarker for breast cancer patients and healthy individuals. 5-(Hydroxymethyl)-2′-deoxycytidine (5-hmdC), 5-(formyl)-2′-deoxycytidine (5-fodC), and 5-(carboxyl)-2′-deoxycytidine (5-cadC) are intermediates in the DNA demethylation pathway and can act as biomarkers. 5-hmdC levels were significantly reduced in urine samples of breast cancer patients, while 5-fodC and 5-cadC levels were elevated. |
Read full article at Wikipedia
|
InChI=1S/C19H28O5S/c1- 18- 9- 7- 13(24- 25(21,22) 23) 11- 12(18) 3- 4- 14- 15- 5- 6- 17(20) 19(15,2) 10- 8- 16(14) 18/h3,13- 16H,4- 11H2,1- 2H3,(H,21,22,23) /t13- ,14- ,15- ,16- ,18- ,19- /m0/s1 |
CZWCKYRVOZZJNM-USOAJAOKSA-N |
C1[C@@]2([C@@]([C@@]3(C(C[C@@H](OS(O)(=O)=O)CC3)=C1)C)(CC[C@]4([C@]2(CCC4=O)[H])C)[H])[H] |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
PubMed
|
EC 2.7.1.33 (pantothenate kinase) inhibitor
An EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitor that interferes with the action of pantothenate kinase (EC 2.7.1.33).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
|
|
View more via ChEBI Ontology
17-oxoandrost-5-en-3β-yl hydrogen sulfate
|
(3-beta)-3-(Sulfooxy)androst-5-en-17-one
|
ChemIDplus
|
17-Ketoandrost-5-en-3beta-yl sulfate
|
ChemIDplus
|
17-oxoandrost-5-en-3β-yl hydrogen sulphate
|
ChEBI
|
3-O-Sulfodehydroepiandrosterone
|
ChemIDplus
|
3beta-Hydroxyandrost-5-en-17-one 3-sulfate
|
KEGG COMPOUND
|
3beta-hydroxyandrost-5-en-17-one 3-sulfate
|
ChEBI
|
3beta-Hydroxyandrost-5-en-17-one 3-sulfate
|
KEGG COMPOUND
|
Androst-5-en-17-on-3beta-yl sulfuric acid
|
ChemIDplus
|
Dehydroepiandrosterone 3-sulfate
|
ChemIDplus
|
Dehydroepiandrosterone monosulfate
|
ChemIDplus
|
Dehydroepiandrosterone sulfate
|
KEGG COMPOUND
|
Dehydroepiandrosterone sulphate
|
ChemIDplus
|
Dehydroisoandrosterone sulfate
|
ChemIDplus
|
Dehydroisoandrosterone-3-sulfate
|
ChemIDplus
|
DHEA sulfate
|
ChemIDplus
|
DHEA sulfate
|
KEGG COMPOUND
|
DHEA-S
|
ChEBI
|
DHEAS
|
ChemIDplus
|
Prasterone sulfate
|
ChemIDplus
|
2227078
|
Reaxys Registry Number
|
Reaxys
|
651-48-9
|
CAS Registry Number
|
ChemIDplus
|
15374110
|
PubMed citation
|
Europe PMC
|
18307294
|
PubMed citation
|
Europe PMC
|
20797618
|
PubMed citation
|
Europe PMC
|
22770225
|
PubMed citation
|
Europe PMC
|
9661815
|
PubMed citation
|
Europe PMC
|
|